Prefera OB plus DHA (Alaven Pharmaceutical LLC)
Welcome to the PulseAid listing for the Prefera OB plus DHA drug offered from Alaven Pharmaceutical LLC. This Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alaven Pharmaceutical LLC |
NON-PROPRIETARY NAME: | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
SUBSTANCE NAME: | FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; POTASSIUM IODIDE; ZINC OXIDE; SELENIUM; CUPRIC SULFATE; CHOLECALCIFEROL; THIAMINE MONONITRATE; ALPHA-TOCOPHEROL SUCCINATE, D-; RIBOFLAVIN; NIACINAMIDE; |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-04-01 |
END MARKETING DATE: | 0000-00-00 |
Prefera OB plus DHA HUMAN PRESCRIPTION DRUG Details:
Item Description | Prefera OB plus DHA from Alaven Pharmaceutical LLC |
LABELER NAME: | Alaven Pharmaceutical LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1; 6; 22; 175; 15; 65; .8; 400; 1.5; 10; 1.6; 17; 50; 12; 30; 10(mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1) |
START MARKETING DATE: | 2009-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68220-089_c697dfae-210c-43a6-b893-f3054e74901c |
PRODUCT NDC: | 68220-089 |
APPLICATION NUMBER: | |
Other FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; POTASSIUM IODIDE; ZINC OXIDE; SELENIUM; CUPRIC SULFATE; CHOLECALCIFEROL; THIAMINE MONONITRATE; ALPHA-TOCOPHEROL SUCCINATE, D-; RIBOFLAVIN; NIACINAMIDE; Pharmaceutical Manufacturers / Labelers: